Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SKYE | THTX | EPRX | ||
| Company | Skye Bioscience Inc | Theratechnologies Inc | Eupraxia Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.85 | 1.6800 | 2.91 | ||
| High | 3.09 | 1.8000 | 3.07 | ||
| Low | 2.66 | 1.5302 | 2.76 | ||
| Last | 2.70 | 1.7900 | 2.99 | ||
| Change | -0.16 | +0.1300 | -0.01 | ||
| % Change | -5.59% | +7.83% | -0.33% | ||
| Volume | 484,700 | 372,300 | 7,700 | ||
| 20-Day Average Volume | 193,830 | 129,755 | 12,130 | ||
| Previous Close | 2.86 | 1.6600 | 3.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.71 | 1.4392 | 3.28 | ||
| 20-Day Raw Stochastic | 2.06% | 91.78% | 26.44% | ||
| 20-Day Relative Strength | 30.67% | 66.36% | 47.02% | ||
| Weighted Alpha | -62.60 | +11.69 | -6.82 | ||
| Today's Opinion | 100% Sell | 88% Buy | 48% Buy | ||
| Previous Opinion | 100% Sell | 56% Buy | 64% Buy | ||
| Last Month's Opinion | 88% Sell | 100% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -20.12% since 12/13/24 | +17.76% since 12/13/24 | -13.16% since 12/13/24 | ||
| Low | 2.66 on 12/20/24 | 1.5200 on 12/16/24 | 2.76 on 12/20/24 | ||
| High | 3.55 on 12/17/24 | 1.8500 on 12/18/24 | 3.50 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | -36.92% since 11/20/24 | +46.72% since 11/20/24 | -16.94% since 11/20/24 | ||
| Low | 2.66 on 12/20/24 | 1.1200 on 11/27/24 | 2.76 on 12/20/24 | ||
| High | 4.60 on 11/29/24 | 1.8500 on 12/18/24 | 3.69 on 11/21/24 | ||
| 3-Month | |||||
| %Chg | -14.01% since 09/20/24 | +44.35% since 09/20/24 | +4.03% since 09/20/24 | ||
| Low | 2.66 on 12/20/24 | 1.1200 on 11/27/24 | 2.20 on 10/14/24 | ||
| High | 5.96 on 11/08/24 | 1.8500 on 12/18/24 | 4.08 on 11/20/24 | ||
| 6-Month | |||||
| %Chg | -69.76% since 06/20/24 | +42.06% since 06/20/24 | +15.00% since 06/20/24 | ||
| Low | 2.66 on 12/20/24 | 1.1200 on 11/27/24 | 2.20 on 10/14/24 | ||
| High | 8.99 on 06/21/24 | 1.8500 on 12/18/24 | 4.08 on 11/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 81,913 | 82,304 | 81,573 | ||
| Shares Outstanding, K | 30,338 | 45,980 | 27,282 | ||
| Annual Sales | 0 | 81,760,000 | 0 | ||
| Annual Net Income | -37,640,000 | -23,960,000 | -28,220,000 | ||
| Last Quarter Sales | 0 | 22,600,000 | 0 | ||
| Last Quarter Net Income | -3,900,000 | 3,090,000 | -5,940,000 | ||
| 60-Month Beta | 1.72 | 1.42 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 11/07/24 | 0.06 on 10/10/24 | -0.17 on 11/07/24 | ||
| Latest Earnings Date | 11/07/24 | 10/10/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||